Quality Assurance and Monitoring
NCI’s Cancer Therapy Evaluation Program (CTEP) Web site has a page dedicated to monitoring of clinical trials for cooperative groups, Community Clinical Oncology Program (CCOP) research bases and the Clinical Trials Support Unit (CTSU).
Clinical Trials Monitoring Service (CTMS) / Theradex®
Theradex® is an international contract research organization providing complete professional services for the clinical research and development of pharmaceutical compounds, medical devices and diagnostic tests in the areas of oncology and life-threatening diseases.
How do I find out about NCI quality assurance/quality control for radiation therapy in international sites?
Quality assurance of radiotherapy dose delivery is overseen by the Radiological Physics Center (RPC) while the required digital data transfer is accomplished through the Advanced Technology Consortium. Depending on the trial group sponsorship, actual reviews are accomplished by the Radiation Therapy Oncology Group (RTOG) the Quality Assurance Review Center (QARC), and the RPC.
How do I find out about NCI quality assurance/quality control for imaging in international sites?
The Centers of Quantitative Imaging Excellence (CQIE) program was developed to establish a resource of “trial ready” sites within the NCI Cancer Centers Program that are capable of conducting clinical trials in which there is an integral molecular and functional advanced imaging endpoint. Currently, CQIE participation is open only to the 58 NCI-designated Cancer Centers. Information about collaborating with U.S. NCI-designated Cancer Centers can be found in the collaborating section of this portal.